AAAAAA

   
Results: 1-15 |
Results: 15
COMBINED NEUTRAL ENDOPEPTIDASE AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN HEART-FAILURE - ROLE OF NATRIURETIC PEPTIDES AND ANGIOTENSIN-II
Authors: RADEMAKER MT CHARLES CJ ESPINER EA NICHOLLS MG RICHARDS AM KOSOGLOU T
Citation: Mt. Rademaker et al., COMBINED NEUTRAL ENDOPEPTIDASE AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN HEART-FAILURE - ROLE OF NATRIURETIC PEPTIDES AND ANGIOTENSIN-II, Journal of cardiovascular pharmacology, 31(1), 1998, pp. 116-125
DISPOSITION OF C-14-EPTIFIBATIDE AFTER INTRAVENOUS ADMINISTRATION TO HEALTHY-MEN
Authors: ALTON KB KOSOGLOU T BAKER S AFFRIME MB CAYEN MN PATRICK JE
Citation: Kb. Alton et al., DISPOSITION OF C-14-EPTIFIBATIDE AFTER INTRAVENOUS ADMINISTRATION TO HEALTHY-MEN, Clinical therapeutics, 20(2), 1998, pp. 307-323
DISPOSITION OF C-14-EPTIFIBATIDE AFTER IV BOLUS ADMINISTRATION IN HEALTHY-SUBJECTS
Authors: KOSOGLOU T ALTON KB BAKER S AFFRIME MB CAYEN MN PATRICK JE
Citation: T. Kosoglou et al., DISPOSITION OF C-14-EPTIFIBATIDE AFTER IV BOLUS ADMINISTRATION IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 51-51
EPTIFIBATIDE PHARMACOKINETICS IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY
Authors: VANWART S KOSOGLOU T TCHENG JE LORENZ T ALTON K BELANGER B RADWANSKI E
Citation: S. Vanwart et al., EPTIFIBATIDE PHARMACOKINETICS IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 103-103
CLEARANCE RECEPTORS AND ENDOPEPTIDASE - EQUAL ROLE IN NATRIURETIC PEPTIDE METABOLISM IN HEART-FAILURE
Authors: RADEMAKER MT CHARLES CJ KOSOGLOU T PROTTER AA ESPINER EA NICHOLLS MG RICHARDS AM
Citation: Mt. Rademaker et al., CLEARANCE RECEPTORS AND ENDOPEPTIDASE - EQUAL ROLE IN NATRIURETIC PEPTIDE METABOLISM IN HEART-FAILURE, American journal of physiology. Heart and circulatory physiology, 42(5), 1997, pp. 2372-2379
PHARMACOKINETICS OF LORATADINE AND PSEUDOEPHEDRINE FOLLOWING SINGLE AND MULTIPLE DOSES OF ONCE-DAILY VERSUS TWICE-DAILY COMBINATION TABLET FORMULATIONS IN HEALTHY ADULT MALES
Authors: KOSOGLOU T RADWANSKI E BATRA VK LIM JM CHRISTOPHER D AFFRIME MB
Citation: T. Kosoglou et al., PHARMACOKINETICS OF LORATADINE AND PSEUDOEPHEDRINE FOLLOWING SINGLE AND MULTIPLE DOSES OF ONCE-DAILY VERSUS TWICE-DAILY COMBINATION TABLET FORMULATIONS IN HEALTHY ADULT MALES, Clinical therapeutics, 19(5), 1997, pp. 1002-1012
CLEARANCE RECEPTORS AND ENDOPEPTIDASE-24.11 - EQUAL ROLE IN NATRIURETIC PEPTIDE METABOLISM IN CONSCIOUS SHEEP
Authors: CHARLES CJ ESPINER EA NICHOLLS MG RICHARDS AM YANDLE TG PROTTER A KOSOGLOU T
Citation: Cj. Charles et al., CLEARANCE RECEPTORS AND ENDOPEPTIDASE-24.11 - EQUAL ROLE IN NATRIURETIC PEPTIDE METABOLISM IN CONSCIOUS SHEEP, American journal of physiology. Regulatory, integrative and comparative physiology, 40(2), 1996, pp. 373-380
NEUTRAL ENDOPEPTIDASE INHIBITION - AUGMENTED ATRIAL AND BRAIN NATRIURETIC PEPTIDE, HEMODYNAMIC AND NATRIURETIC RESPONSES IN OVINE HEART-FAILURE
Authors: RADEMAKER MT CHARLES CJ ESPINER EA NICHOLLS MG RICHARDS AM KOSOGLOU T
Citation: Mt. Rademaker et al., NEUTRAL ENDOPEPTIDASE INHIBITION - AUGMENTED ATRIAL AND BRAIN NATRIURETIC PEPTIDE, HEMODYNAMIC AND NATRIURETIC RESPONSES IN OVINE HEART-FAILURE, Clinical science, 91(3), 1996, pp. 283-291
INFLUENCE OF FOOD ON THE ORAL BIOAVAILABILITY OF LORATADINE AND PSEUDOEPHEDRINE FROM EXTENDED-RELEASE TABLETS IN HEALTHY-VOLUNTEERS
Authors: NOMEIR AA MOJAVERIAN P KOSOGLOU T AFFRIME MB NEZAMIS J RADWANSKI E LIN CC CAYEN MN
Citation: Aa. Nomeir et al., INFLUENCE OF FOOD ON THE ORAL BIOAVAILABILITY OF LORATADINE AND PSEUDOEPHEDRINE FROM EXTENDED-RELEASE TABLETS IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(10), 1996, pp. 923-930
EFFECT OF SCH-48461 ON ORAL CHOLESTEROL ABSORPTION
Authors: CUTLER D KOSOGLOU T SABO R AFFRIME M KATZ A GINSBERG H
Citation: D. Cutler et al., EFFECT OF SCH-48461 ON ORAL CHOLESTEROL ABSORPTION, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 23-23
EFFECT OF FOOD AND POSTPRANDIAL STATE ON THE BIOAVAILABILITY OF MICRONIZED PROGESTERONE
Authors: KOSOGLOU T MOJAVERIAN P RADWANSKI E CHRISTOPHER D CUTLER DL LIN CC AFFRIME MB
Citation: T. Kosoglou et al., EFFECT OF FOOD AND POSTPRANDIAL STATE ON THE BIOAVAILABILITY OF MICRONIZED PROGESTERONE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 24-24
PHARMACOKINETICS OF ISOSORBIDE-5-MONONITRATE AFTER ORAL-ADMINISTRATION OF AN EXTENDED-RELEASE MONONITRATE FORMULATION VERSUS A STANDARD DINITRATE FORMULATION
Authors: KOSOGLOU T PATRICK JE COHEN A RADWANSKI E CHRISTOPHER DC AFFRIME MB
Citation: T. Kosoglou et al., PHARMACOKINETICS OF ISOSORBIDE-5-MONONITRATE AFTER ORAL-ADMINISTRATION OF AN EXTENDED-RELEASE MONONITRATE FORMULATION VERSUS A STANDARD DINITRATE FORMULATION, Clinical therapeutics, 17(2), 1995, pp. 241-251
EFFECT OF FOOD ON THE ORAL BIOAVAILABILITY OF ISOSORBIDE-5-MONONITRATE ADMINISTERED AS AN EXTENDED-RELEASE TABLET
Authors: KOSOGLOU T KAZIERAD DJ SCHENTAG JJ PATRICK JE HEIMARK L RADWANSKI E CHRISTOPHER D FLANNERY BE AFFRIME MB
Citation: T. Kosoglou et al., EFFECT OF FOOD ON THE ORAL BIOAVAILABILITY OF ISOSORBIDE-5-MONONITRATE ADMINISTERED AS AN EXTENDED-RELEASE TABLET, Journal of clinical pharmacology, 35(2), 1995, pp. 151-158
PHARMACOKINETIC PHARMACOKINETIC (PK-PD) MODELING FOR A NEW ANTIHYPERTENSIVE AGENT (NEUTRAL METALLOENDOPEPTIDASE INHIBITOR SCH-42354) IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION
Authors: FETTNER SH PAI S ZHU GR KOSOGLOU T BANFIELD CR BATRA V
Citation: Sh. Fettner et al., PHARMACOKINETIC PHARMACOKINETIC (PK-PD) MODELING FOR A NEW ANTIHYPERTENSIVE AGENT (NEUTRAL METALLOENDOPEPTIDASE INHIBITOR SCH-42354) IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, European Journal of Clinical Pharmacology, 48(5), 1995, pp. 351-359
ENDOPEPTIDASE-24.11 INHIBITION BY SCH-42495 IN ESSENTIAL-HYPERTENSION
Authors: RICHARDS AM CROZIER IG KOSOGLOU T RALLINGS M ESPINER EA NICHOLLS MG YANDLE TG IKRAM H FRAMPTON C
Citation: Am. Richards et al., ENDOPEPTIDASE-24.11 INHIBITION BY SCH-42495 IN ESSENTIAL-HYPERTENSION, Hypertension, 22(1), 1993, pp. 119-126
Risultati: 1-15 |